Effect of Gefitinib in the Treatment of EGFR Positive Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer Patients and Its Influence on EGFR and P-Akt

Effect of Gefitinib in the Treatment of EGFR Positive Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer Patients and Its Influence on EGFR and P-Akt

YUAN Hui, XU Yang, ZHANG Juan

PDF(989 KB)

PDF(989 KB)

Chinese And Foreign Medical Research ›› 2023, Vol. 21 ›› Issue (1) : 45-48. DOI: 10.14033/j.cnki.cfmr.2023.01.011

Clinical practice

Effect of Gefitinib in the Treatment of EGFR Positive Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer Patients and Its Influence on EGFR and P-Akt

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 21(1): 45-48 https://doi.org/10.14033/j.cnki.cfmr.2023.01.011

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(989 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉